Ghana vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Ghana rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Kazakhstan
How they compare
Ghana currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 16 shared years of data; in 2008 it was Kazakhstan ahead.
Ghana ranks 1st and Kazakhstan ranks 1st of 180 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 48.0% | 35.0% | Kazakhstan |
| 2010s | 68.2% | 87.4% | 19.2% | Kazakhstan |
| 2020s | 98.6% | 100.0% | 1.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Kazakhstan?
- Ghana, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Kazakhstan?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Kazakhstan?
- 16 years are reported by both, from 2008 to 2024.
- How do Ghana and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.